Revance Therapeutics shares owned by Assetmark
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Assetmark
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $335 | 68 | 4.93 |
2023-12-31 | $18k | 2.0k | 8.79 |
2023-09-30 | $37k | 3.3k | 11.47 |
2023-06-30 | $51k | 2.0k | 25.31 |
2015-12-31 | $0 | 14 | 0.00 |